S. Korea open to use of Ebola drug on new coronavirus after full clinical testing
SEOUL, April 30 (Yonhap) -- South Korea will allow the use of an Ebola virus drug in treating coronavirus patients if the drug proves to be effective and safe through clinical tests, officials said Thursday.
The drug, Remdesivir, has drawn keen attention since the U.S. National Institute of Allergy and Infectious Diseases (NIAID) said its tests showed that the drug "accelerates recovery" of COVID-19 patients.
"It is true that some positive effects are being mentioned about Remdesivir," Deputy Director Kwon Jun-wook of the Korea Centers for Disease Control and Prevention said during a daily briefing. "In case of contingencies, we will try to give it emergency use authorization and allow its domestic use."
The NIAID said in a statement released on Wednesday that hospitalized patients with advanced COVID-19 and lung involvement, who received Remdesivir, recovered faster than similar patients who received placebo.
Under cooperation with the drug's maker, Gilead Sciences, three hospitals in South Korea are also carrying out clinical tests of the drug on some 200 COVID-19 patients.
Kwon said, however, that its use can be allowed only after full clinical test results are reviewed.
"At this point in time, the full clinical test results have not been tallied yet," he said. "The disease control center and experts will keep looking into the results as they come in and make necessary preparations."
colin@yna.co.kr
(END)
-
S. Korea to resume issuing short-term travel visas, e-visas next month
-
Ateez to drop new Japanese EP next week
-
(2nd LD) BTS wins three Billboard Music Awards, marking 6th year to win an award
-
Crypto investor probed over allegedly visiting house of Terraform's CEO
-
(2nd LD) N. Korea still unresponsive to S. Korea's outreach for talks on COVID-19: official
-
S. Korea to resume issuing short-term travel visas, e-visas next month
-
(LEAD) Yoon, PPP lawmakers travel to Gwangju en masse to commemorate 1980 democracy uprising
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(LEAD) At least 8 injured in S-Oil refinery explosion in Ulsan: firefighters
-
(LEAD) Biden set to arrive in S. Korea for first summit with Yoon
-
First lady Kim to greet Biden before state dinner
-
(5th LD) Yoon, Biden agree to expand joint military exercises to cope with N.K. threats
-
(2nd LD) Yoon, Biden hold first summit on N. Korea, economy
-
Biden calls Moon 'good friend' in phone conversation: Moon's aide
-
Full text of joint statement issued after Yoon-Biden summit